NPM1 and acute myeloid leukemia: The analysis of the overall survival of NPM1-mut AML patients showed a marked heterogeneity, with a part of patients showing a good OS, with an observed risk hazard distributed between favorable and intermediate ELN risk groups and another part of patients showing a poor OS with an observed risk hazard distributed between intermediate and adverse ELN risk groups [2].